跳至主要内容
临床试验/EUCTR2016-003973-16-NL
EUCTR2016-003973-16-NL进行中(未招募)1 期

Groningen International Study on Sentinel nodes in Vulvar cancer - III, a prospective phase 2 treatment trial - GROINSS-V III

niversity Medical Center Groningen0 个研究点目标入组 157 人开始时间: 2019年3月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
157

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Histological confirmed primary SCC of the vulva
  • - T1 tumor, not encroaching urethra/vagina/anus
  • - Depth of invasion > 1mm
  • - Tumor diameter < 4cm
  • - Unifocal tumors
  • - No enlarged (>1.5cm) or suspicious inguinofemoral lymph nodes at imaging (CT/MRI/ultrasound)
  • - Possibility to obtain informed consent
  • - Metastatic sentinel lymph node; size of metastasis > 2mm
  • - Metastatic sentinel lymph node: more than 1 SN with metastasis = 2mm
  • - Patients are able to understand requirements of study, provide written informed consent and comply with the study and follow-up procedures
  • . Adequate bone marrow, renal and liver function:
  • Absolute neutrophil count = 1.5 x 109 /L
  • Platelet count = 100 x 109 /L
  • Creatinine clearance = 40 ml/min measured by the Cockroft Gault formula
  • Total bilirubin < 1.25 x ULN
  • Aspartate transaminase (AST) and alanine transaminase (ALT) = 2.5 x ULN
  • - Performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) Scale
  • - Age 18 years or older
  • - Life expectancy of = 12 weeks
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 82
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 75

排除标准

  • - Inoperable tumors and tumors > 4cm
  • - Multifocal tumors
  • - Tumors with other pathology than squamous cell carcinoma
  • - Patients with enlarged / suspicious lymph nodes which are proven metastatic after fine needle aspiration cytology
  • - No other carcinomas, other than basal cell carcinomas, within last 5 years
  • - History of pelvic radiotherapy
  • - History of any infection requiring hospitalization or antibiotics within 2 weeks before enrollment
  • - Pregnant female or nursing mother
  • - Known brain or spinal cord metastases unless adequately treated (surgery or radiotherapy) with no evidence of progression and neurologically stable off anticonvulsants and steroids
  • - Unstable angina, myocardial infarction, cerebrovascular accident, > Class II congestive heart failure according to the New York Heart Association Classification for Congestive Heart Failure within 6 months before enrollment

研究者

相似试验

Chemoradiation in vulvar cancer patients with... | 临床试验